TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy.
- Resource Type
- Article
- Source
- Acta Biomaterialia; Apr2022, Vol. 143, p392-405, 14p
- Subject
TARGETED drug delivery TRIPLE-negative breast cancer IMMUNOTHERAPY DEATH receptors DRUG delivery systems DENDRITIC cells T cells NANOMEDICINE - Language
- ISSN
- 17427061